Literature DB >> 23400560

The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction.

Natalie L Marchant1, Bruce R Reed, Nerses Sanossian, Cindee M Madison, Stephen Kriger, Roxana Dhada, Wendy J Mack, Charles DeCarli, Michael W Weiner, Dan M Mungas, Helena C Chui, William J Jagust.   

Abstract

IMPORTANCE: β-Amyloid (Aβ) deposition and vascular brain injury (VBI) frequently co-occur and are both associated with cognitive decline in aging. Determining whether a direct relationship exists between them has been challenging. We sought to understand VBI's influence on cognition and clinical impairment, separate from and in conjunction with pathologic changes associated with Alzheimer disease (AD).
OBJECTIVE: To examine the relationship between neuroimaging measures of VBI and brain Aβ deposition and their associations with cognition. DESIGN AND
SETTING: A cross-sectional study in a community- and clinic-based sample recruited for elevated vascular disease risk factors. PARTICIPANTS: Clinically normal (mean age, 77.1 years [N = 30]), cognitively impaired (mean age, 78.0 years [N = 24]), and mildly demented (mean age, 79.8 years [N = 7]) participants.
INTERVENTIONS: Magnetic resonance imaging, Aβ (Pittsburgh Compound B-positron emission tomographic [PiB-PET]) imaging, and cognitive testing. MAIN OUTCOME MEASURES: Magnetic resonance images were rated for the presence and location of infarct (34 infarct-positive participants, 27 infarct-negative participants) and were used to quantify white matter lesion volume. The PiB-PET uptake ratios were used to create a PiB index by averaging uptake across regions vulnerable to early Aβ deposition; PiB positivity (29 PiB-positive participants, 32 PiB-negative participants) was determined from a data-derived threshold. Standardized composite cognitive measures included executive function and verbal and nonverbal memory.
RESULTS: Vascular brain injury and Aβ were independent in both cognitively normal and impaired participants. Infarction, particularly in cortical and subcortical gray matter, was associated with lower cognitive performance in all domains (P < .05 for all comparisons). Pittsburgh Compound B positivity was neither a significant predictor of cognition nor interacted with VBI. CONCLUSIONS AND RELEVANCE: In this elderly sample with normal cognition to mild dementia, enriched for vascular disease, VBI was more influential than Aβ in contemporaneous cognitive function and remained predictive after including the possible influence of Aβ. There was no evidence that VBI increases the likelihood of Aβ deposition. This finding highlights the importance of VBI in mild cognitive impairment and suggests that the impact of cerebrovascular disease should be considered with respect to defining the etiology of mild cognitive impairment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23400560      PMCID: PMC3771392          DOI: 10.1001/2013.jamaneurol.405

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  46 in total

1.  Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

Authors:  Victor L Villemagne; Kerryn E Pike; Gaël Chételat; Kathryn A Ellis; Rachel S Mulligan; Pierrick Bourgeat; Uwe Ackermann; Gareth Jones; Cassandra Szoeke; Olivier Salvado; Ralph Martins; Graeme O'Keefe; Chester A Mathis; William E Klunk; David Ames; Colin L Masters; Christopher C Rowe
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

2.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

Review 3.  Neuroanatomical substrates of age-related cognitive decline.

Authors:  Timothy A Salthouse
Journal:  Psychol Bull       Date:  2011-09       Impact factor: 17.737

4.  Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation.

Authors:  Xian Zhang; Kun Zhou; Ruishan Wang; Jiankun Cui; Stuart A Lipton; Francesca-Fang Liao; Huaxi Xu; Yun-wu Zhang
Journal:  J Biol Chem       Date:  2007-02-15       Impact factor: 5.157

5.  Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease.

Authors:  I Prohovnik; D P Perl; K L Davis; L Libow; G Lesser; V Haroutunian
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

Review 6.  Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.

Authors:  Abhay P Sagare; Robert D Bell; Berislav V Zlokovic
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 7.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

8.  Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.

Authors:  Chester A Mathis; Yanming Wang; Daniel P Holt; Guo-Feng Huang; Manik L Debnath; William E Klunk
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

9.  Prevalence of dementia disorders in the oldest-old: an autopsy study.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  Acta Neuropathol       Date:  2010-03-04       Impact factor: 17.088

10.  Cognition, reserve, and amyloid deposition in normal aging.

Authors:  Dorene M Rentz; Joseph J Locascio; John A Becker; Erin K Moran; Elisha Eng; Randy L Buckner; Reisa A Sperling; Keith A Johnson
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

View more
  53 in total

1.  Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.

Authors:  Jennifer S Rabin; Aaron P Schultz; Trey Hedden; Anand Viswanathan; Gad A Marshall; Emily Kilpatrick; Hannah Klein; Rachel F Buckley; Hyun-Sik Yang; Michael Properzi; Vaishnavi Rao; Dylan R Kirn; Kathryn V Papp; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Jasmeer P Chhatwal
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

2.  Multimorbidity and neuroimaging biomarkers among cognitively normal persons.

Authors:  Maria Vassilaki; Jeremiah A Aakre; Michelle M Mielke; Yonas E Geda; Walter K Kremers; Rabe E Alhurani; Mary M Machulda; David S Knopman; Ronald C Petersen; Val J Lowe; Clifford R Jack; Rosebud O Roberts
Journal:  Neurology       Date:  2016-04-13       Impact factor: 9.910

3.  Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment.

Authors:  Sylvia Villeneuve; William J Jagust
Journal:  J Prev Alzheimers Dis       Date:  2015-03

4.  Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury.

Authors:  Charles DeCarli; Sylvia Villeneuve; Pauline Maillard; Danielle Harvey; Baljeet Singh; Owen Carmichael; Evan Fletcher; John Olichney; Sarah Farias; William Jagust; Bruce Reed; Dan Mungas
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 5.  Detectable Neuropsychological Differences in Early Preclinical Alzheimer's Disease: A Meta-Analysis.

Authors:  S Duke Han; Caroline P Nguyen; Nikki H Stricker; Daniel A Nation
Journal:  Neuropsychol Rev       Date:  2017-05-11       Impact factor: 7.444

6.  Amyloid burden, cerebrovascular disease, brain atrophy, and cognition in cognitively impaired patients.

Authors:  Byoung Seok Ye; Sang Won Seo; Geon Ha Kim; Young Noh; Hanna Cho; Cindy W Yoon; Hee Jin Kim; Juhee Chin; Seun Jeon; Jong Min Lee; Joon-Kyung Seong; Jae Seung Kim; Jae-Hong Lee; Yearn Seong Choe; Kyung Han Lee; Young H Sohn; Michael Ewers; Michael Weiner; Duk L Na
Journal:  Alzheimers Dement       Date:  2014-07-19       Impact factor: 21.566

Review 7.  Alzheimer disease therapy--moving from amyloid-β to tau.

Authors:  Ezio Giacobini; Gabriel Gold
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

Review 8.  Role of HIV in amyloid metabolism.

Authors:  Mario Ortega; Beau M Ances
Journal:  J Neuroimmune Pharmacol       Date:  2014-05-10       Impact factor: 4.147

9.  Synergistic effects of ischemia and β-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment.

Authors:  Mi Ji Lee; Sang Won Seo; Duk L Na; Changsoo Kim; Jae Hyun Park; Geon Ha Kim; Chi Hun Kim; Young Noh; Hanna Cho; Hee Jin Kim; Cindy W Yoon; Byoung Seok Ye; Juhee Chin; Seun Jeon; Jong-Min Lee; Yearn Seong Choe; Kyung-Han Lee; Jae Seung Kim; Sung Tae Kim; Jae-Hong Lee; Michael Ewers; David J Werring; Michael W Weiner
Journal:  JAMA Psychiatry       Date:  2014-04       Impact factor: 21.596

10.  Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation.

Authors:  Rosebud O Roberts; David S Knopman; Ruth H Cha; Michelle M Mielke; V Shane Pankratz; Bradley F Boeve; Kejal Kantarci; Yonas E Geda; Clifford R Jack; Ronald C Petersen; Val J Lowe
Journal:  J Nucl Med       Date:  2014-03-20       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.